Charles River raises annual profit view as it sells underperforming assets
Charles RiverCharles River(US:CRL) Reuters·2026-02-25 13:00

Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv Charles River raises annual profit view as it sells underperforming assets February 25, 20261:00 PM UTCUpdated ago By Reuters Feb 25 (Reuters) - Contract drug developer Charles River Laboratories (CRL.N), opens new tab raised its 2026 profit forecast on Wednesday, after it announced the sales of some underperforming assets to peer IQVIA (IQV.N), opens new tab and private equity firm GI Partner ...